Another study evaluated the effectiveness of the clinically disapproved drug DHA (Docosahexaenoic acid) on IPSC-derived neurons from AD patients carrying APP-E693, APP-V717L, and sporadic AD mutant (AD8K213). The gene discussed is APP; the disease is Alzheimer disease.